The algorithm integrates with EHR systems and ECG platforms, operating within the health system without external data ...

"ACC 2026: Sotatercept shows signal in CpcPH-HFpEF at lower dose" was originally created and published by Pharmaceutical ...

Patients who have heart failure with preserved ejection fraction (HFpEF) and high blood pressure in the lungs (pulmonary ...

Merck (NYSE:MRK) is approaching phase 2 data for Winrevair in pulmonary hypertension. Results will focus on the 6 minute walk ...

Doctors say pulmonary veno-occlusive disease affects about 2 in 1 million people and is often difficult to diagnose.

Pulmonary arterial hypertension, or PAH, is a rare and severe disease characterized by elevated blood pressure in the pulmonary arteries, which transport blood from the heart to the lungs. This can ...

Pulmonary arterial hypertension (PAH) is a type of high blood pressure in the arteries that go from your heart to your lungs. It happens when these arteries become narrow or blocked, making it harder ...

Digital twin technology could personalize treatment for pulmonary hypertension, according to a recent study. The concept of a digital twin involves creating a virtual model of a patient that can be ...

In late March 2026, Liquidia’s Chief Commercial Officer Scott Moomaw exercised and immediately sold 80,000 shares under a pre-arranged Rule 10b5-1 trading plan, while retaining 188,954 shares. Around ...

Arteries are blood vessels that carry blood away from your heart. Pulmonary arterial hypertension (PAH) is a condition where you have high blood pressure in the arteries that go from your heart to ...